Public versus Private Drug Insurance and Outcomes of Patients Requiring Biologic Therapies for Inflammatory Bowel Disease.
about
Public versus Private Drug Insurance and Outcomes of Patients Requiring Biologic Therapies for Inflammatory Bowel Disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 January 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Public versus Private Drug Ins ...... or Inflammatory Bowel Disease.
@en
Public versus Private Drug Ins ...... or Inflammatory Bowel Disease.
@nl
type
label
Public versus Private Drug Ins ...... or Inflammatory Bowel Disease.
@en
Public versus Private Drug Ins ...... or Inflammatory Bowel Disease.
@nl
prefLabel
Public versus Private Drug Ins ...... or Inflammatory Bowel Disease.
@en
Public versus Private Drug Ins ...... or Inflammatory Bowel Disease.
@nl
P2093
P2860
P356
P1476
Public versus Private Drug Ins ...... for Inflammatory Bowel Disease
@en
P2093
A Hillary Steinhart
Amir Rumman
Justina J Sam
Kenneth Croitoru
Mark S Silverberg
P2860
P304
P356
10.1155/2017/7365937
P407
P577
2017-01-23T00:00:00Z